Erifili E. Hatziagelaki
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Cardio-renal-metabolic syndrome: A concept in question, a clinical impact beyond doubt.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: January 15, 2026
Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.
Journal: JAMA
Published: December 08, 2025
Hydrogen sulfide to modulate Glycated hemoglobin and gut microbiome in type 2 diabetes mellitus.
Journal: Metabolism open
Published: September 01, 2025
Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: June 03, 2025
Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS-Randomized Controlled Study and Volatomics Analysis.
Journal: Nutrients
Published: April 10, 2025
Evaluation of Quality of Life and Emotional Disturbances in Patients with Diabetic Retinopathy.
Journal: European journal of investigation in health, psychology and education
Published: September 16, 2023
NAFLD and thyroid function: pathophysiological and therapeutic considerations.
Journal: Trends in endocrinology and metabolism: TEM
Published: May 12, 2022
A Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut!
Journal: Microorganisms
Published: February 22, 2022
GLP-1RAs for the treatment of obesity in women after menopause.
Journal: Maturitas
Published: December 06, 2021
Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept.
Journal: Journal of cardiovascular pharmacology
Published: January 24, 2021
Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Journal: Molecules (Basel, Switzerland)
Published: September 29, 2020
Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: August 12, 2020
Last Updated: 09/26/2026